Tenon Medical, Inc. 8-K

What Happened

• On March 19, 2026, Tenon Medical, Inc. (TNON) announced its financial results for the fourth quarter and fiscal year ended December 31, 2025 via a press release and filed a Current Report on Form 8-K (Item 2.02). The company hosted a conference call the same day to discuss the results, provide a corporate update, and answer questions from its covering analyst.

Key Details

• Announcement and filing date: March 19, 2026 (Form 8-K Item 2.02).
• Period covered: fourth quarter and fiscal year ended December 31, 2025.
• Conference call: March 19, 2026 at 4:30 p.m. ET (1:30 p.m. PT); audio playback available through April 22, 2026 at http://ir.tenonmed.com/ or by phone (US: 1-844-512-2921; Intl: 1-412-317-6671) using access code 13758268.
• The press release announcing the results is furnished as Exhibit 99.1 to the Form 8-K; the filing notes the furnished information is not “filed” for purposes of Section 18 of the Exchange Act.

Why It Matters

• This 8-K is the company’s official release of its quarterly and full-year 2025 results and management commentary. Retail investors should review the press release (Exhibit 99.1) and the conference call replay for the specific financial metrics—such as revenue, profitability, and any management guidance—that can affect TNON’s near-term outlook and stock performance.